0J8P:LSE:LSE-IDEXX Laboratories Inc. (USD)

COMMON STOCK | |

Last Closing

USD 411.9199

Change

-15.01 (-3.52)%

Market Cap

USD 3,896.33B

Volume

350.00

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

IDEXX Laboratories, Inc. develops, manufactures, and distributes products primarily for the companion animal veterinary, livestock and poultry, dairy, and water testing markets in Africa, the Asia Pacific, Canada, Europe, Latin America, and internationally. The company operates through three segments: Companion Animal Group; Water Quality Products; and Livestock, Poultry and Dairy. It also provides point-of-care veterinary diagnostic products, including instruments, consumables, and rapid assay test kits; veterinary reference laboratory diagnostic and consulting services; practice management and diagnostic imaging systems and services for veterinarians; and health monitoring, biological materials testing, and laboratory diagnostic instruments, and services for biomedical research community. In addition, the company offers diagnostic and health-monitoring products for livestock, poultry, and dairy; products that test water for various microbiological contaminants; point-of-care electrolytes and blood gas analyzers; in-clinic chemistry, blood and urine chemistry, hematology, immunoassay, urinalysis, and coagulation analyzers; and SNAP rapid assays test kits. Further, it provides Colilert, Colilert-18, and Colisure tests, which detect the presence of total coliforms and E. coli in water; Enterolert, Pseudalert, Filta-Max and Filta-Max xpress, Legiolert, and Quanti-Tray products; and veterinary software and services for independent veterinary clinics and corporate groups. Additionally, the company offers human medical point-of-care products and laboratory diagnostics services. The company markets its products through marketing, customer service, sales, and technical service groups, as well as through independent distributors and other resellers. IDEXX Laboratories, Inc. was incorporated in 1983 and is headquartered in Westbrook, Maine.

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-11-15 )

Largest Industry Peers for

Symbol Name Price(Change) Market Cap
0R2T:LSE Micron Technology Inc

+7.99 (+9.02%)

USD 9,223,372,036.85B
0R37:LSE Berkshire Hathaway Inc

+0.75 (+0.16%)

USD 9,223,372,036.85B
0R2V:LSE Apple Inc.

-1.00 (-0.44%)

USD 9,223,372,036.85B
0R2F:LSE Wells Fargo & Company

+0.30 (+0.40%)

USD 9,223,372,036.85B
0R15:LSE SoftBank Group Corp.

-253.00 (-2.76%)

USD 9,217.80B
0R1E:LSE Nintendo Co. Ltd.

+108.00 (+1.32%)

USD 7,596.04B
0M69:LSE OTP Bank Nyrt

N/A

USD 5,014.80B
0R1X:LSE General Mills Inc.

-1.91 (-2.93%)

USD 3,910.53B
0LC3:LSE Synchrony Financial

+0.12 (+0.18%)

USD 3,907.58B
0HKE:LSE Axon Enterprise Inc.

-9.64 (-1.59%)

USD 3,893.44B

ETFs Containing 0J8P:LSE

N/A

Market Performance

  Market Performance vs. Industry/Classification () Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -25.81% N/A N/A 14% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -25.81% N/A N/A 14% F
Trailing 12 Months  
Capital Gain -10.78% N/A N/A 20% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -10.78% N/A N/A 20% F
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain 1.90% N/A N/A 42% F
Dividend Return 1.90% N/A N/A 42% F
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 21.62% N/A N/A 46% F
Risk Adjusted Return 8.81% N/A N/A 42% F
Market Capitalization 3,896.33B N/A N/A 100% F

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Positive cash flow

The company had positive total cash flow in the most recent four quarters.

What to not like:

There is nothing we particularly dislike